![James Ahlers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Ahlers
Directeur Financier/CFO chez
CUE BIOPHARMA, INC.
Fortune : 650 760 $ au 31/08/2026
Profil
Mr. James M.
Ahlers is a Chief Financial Officer at Cue Biopharma, Inc. Mr. Ahlers was previously employed as an Executive Vice President-Corporate Finance by Intensity Therapeutics, Inc., a Chief Financial Officer by RenovoRx, Inc., a Chief Financial Officer by Intarcia Therapeutics, Inc., a Director-Finance & Administration by Ansan Pharmaceuticals, Inc., a Financial Consultant by Cytokinetics, Inc., a Member-Audit Department by Deloitte & Touche LLP, a Financial Consultant by Genesoft Pharmaceuticals, Inc., a Manager-Financial Planning & Analysis by Medco Behavioral Care Corp., a Director-Finance & Administration by Titan Pharmaceuticals, Inc., and a Financial Consultant by Tularik, Inc. He received his undergraduate degree from the University of San Francisco.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CUE BIOPHARMA, INC. 0,35 % | 30/07/2026 | 25 500 ( 0,35 % ) | 650 760 $ | 31/08/2026 |
Postes actifs de James Ahlers
| Sociétés | Poste | Début |
|---|---|---|
| CUE BIOPHARMA, INC. | Directeur Financier/CFO | 30/07/2026 |
Anciens postes connus de James Ahlers
| Sociétés | Poste | Fin |
|---|---|---|
| INTENSITY THERAPEUTICS, INC. | Corporate Officer/Principal | 21/05/2024 |
| RENOVORX, INC. | Directeur Financier/CFO | 05/02/2024 |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Directeur Financier/CFO | 01/11/2019 |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Corporate Officer/Principal | - |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Corporate Officer/Principal | - |
Formation de James Ahlers
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
63
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Titan Pharmaceuticals, Inc.
 Titan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes proprietary therapeutics for the treatment of serious medical disorders | Health Technology |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Commercial Services |
Genesoft Pharmaceuticals, Inc.
 Genesoft Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops anti-infective products | Commercial Services |
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Intensity Therapeutics, Inc.
 Intensity Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company which develops and markets proprietary intratumoral immunotherapy products for cancer treatment | Health Technology |
RenovoRx, Inc.
 RenovoRx, Inc. Medical SpecialtiesHealth Technology Provides infusion therapy devices for treatment of tumors | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
Medco Behavioral Care Corp.
 Medco Behavioral Care Corp. Pharmaceuticals: MajorHealth Technology Behavioral health management | Health Technology |
University of San Francisco
 University of San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Health Technology |
Ansan Pharmaceuticals, Inc.
 Ansan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
